New Medicine by Design-funded research illuminates the role of a little-understood immune cell
New research sheds light on the role of monocytes.
New research sheds light on the role of monocytes.
New research is a step forward to cell therapies for liver disease
“It’s an incredibly exciting time in regenerative medicine. There are a few hurdles in the way to achieving what we want, but I believe great things that will have a positive impact on society are absolutely possible.”
"My next career goal is to become a physician-scientist. This role would enable me to practice the two areas I love – applied research and caring for people’s health."
Medicine by Design welcomes Jesse Gillis, a computational biology expert.
Program to fully fund summer positions in Medicine by Design labs beginning in summer 2022.
Catalyst Grants co-awarded to research projects that hold promise in strengthening the connection between data science innovation and regenerative medicine.
Study is an important step forward in researchers’ understanding of treating damaged hearts with cell therapies.
Program selects inaugural incubator companies
Several Medicine by Design-funded investigators were named Canada Research Chairs, and two received New Frontiers in Research Fund (NFRF) Transformation stream grants.
Projects to impact autoimmune, intestinal and degenerative eye diseases
Research shows that transplanted pancreatic cells were able to survive in animal hosts.
"Our lab’s work is a good example of why it’s an exciting time to be in regenerative medicine: tissue engineering and regenerative medicine strategies enable us to model a disease in the lab, which can help us answer big unknowns."
Themes like lessons learned from COVID-19, symbiotic partnerships and access to risk capital emerge in wide-ranging discussion.
Is immunoengineering the key to ensuring that cell therapies can treat disease?